1. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. (October 2019) Authors: Urun, Yuksel; Yasar, H Arzu; Turna, Hande; Esin, Ece; Sedef, A Murat; Alkan, Ali; Oksuzoglu, Berna; Ozdemir, Nuriye; Sendur, MA Nahit; Sezer, Ahmet; Kılıckap, Saadettin; Utkan, Gungor; Akman, Tulay; Akbulut, Hakan; Celik, Ismail; Abalı, Huseyin Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 7(2019) Page Start: 1658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?. (December 2019) Authors: Ürün, Yüksel; Yaşar, H Arzu; Turna, Hande; Kılıçkap, Saadettin; Sezer, Ahmet; Öksüzoğlu, Berna; Özdemir, Nuriye; Şendur, MA Nahit; Abalı, Hüseyin Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 8(2019) Page Start: 2062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. (March 2020) Authors: Arzu Yaşar, H; Turna, Hande; Esin, Ece; Murat Sedef, A; Alkan, Ali; Oksuzoglu, Berna; Ozdemir, Nuriye; Sendur, MA Nahit; Sezer, Ahmet; Kılıckap, Saadettin; Utkan, Gungor; Akbulut, Hakan; Celik, Ismail; Abalı, Huseyin; Urun, Yuksel Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 2(2020) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Acute fatal interstitial lung disease in two cases under treatment of crizotinib. Issue 7 (2016) Authors: Sedef, Ali Murat; Köse, Fatih; Sümbül, Ahmet Taner; Sezer, Ahmet; Beşen, Ali Ayberk; Mertsoylu, Hüseyin; Özyılkan, Özgür Journal: Clinical case reports and reviews Issue: Volume 2:Issue 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of confidence intervals for the Behrens-Fisher problem. Issue 4 (21st April 2017) Authors: Sezer, Ahmet; Ozkip, Evren; Yazici, Berna Journal: Communications in statistics Issue: Volume 46:Issue 4(2017) Page Start: 3242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience. Issue 12 (December 2021) Authors: Acibuca, Aynur; Sezer, Ahmet; Yilmaz, Mustafa; Sumbul, Ahmet Taner; Demircan, Senol; Muderrisoglu, Ibrahim Haldun; Ozyilkan, Ozgur Journal: Journal of international medical research Issue: Volume 49:Issue 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multiple Comparison of Age Groups in Bone Mineral Density under Heteroscedasticity. (27th August 2015) Authors: Sezer, Ahmet; Altan, Lale; Özdemir, Özer Other Names: Smith Heather F. Academic Editor. Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group. Issue 50 (16th December 2022) Authors: Gürbüz, Mustafa; Kiliçkap, Saadettin; Bilici, Ahmet; Karadurmuş, Nuri; Sezer, Ahmet; Şendur, Mehmet Ali Nahit; Paydaş, Semra; Artaç, Mehmet; Fulden Yumuk, Perran; Gürsoy, Pinar; Uysal, Mükremin; Şenol Coşkun, Hasan; Tatli, Ali Murat; Selçukbiricik, Fatih; Dişel, Umut; Köksoy, Elif Berna; Güven, D... Journal: Medicine Issue: Volume 101:Issue 50(2022) Page Start: e32368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study. Issue 1 (29th October 2022) Authors: Gümüş, Mahmut; Chen, Chieh‐I; Ivanescu, Cristina; Kilickap, Saadettin; Bondarenko, Igor; Özgüroğlu, Mustafa; Gogishvili, Miranda; Turk, Haci M.; Cicin, Irfan; Harnett, James; Mastey, Vera; Naumann, Ulrike; Reaney, Matthew; Konidaris, Gerasimos; Sasane, Medha; Brady, Keri J. S.; Li, Siyu; Gullo, G... Journal: Cancer Issue: Volume 129:Issue 1(2023) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy. (7th October 2020) Authors: Topkan, Erkan; Ozdemir, Yurday; Kucuk, Ahmet; Guler, Ozan Cem; Sezer, Ahmet; Besen, Ali Ayberk; Mertsoylu, Huseyin; Senyurek, Sukran; Kilic Durankus, Nulifer; Bolukbasi, Yasemin; Selek, Ugur; Pehlivan, Berrin Other Names: Kanat Ozkan Academic Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗